Cases & Deals

TGR BioSciences executes patent strategy facilitating successful merger with Sygnis

Clients TGR BioSciences Pty Ltd

Jones Day developed and executed the patent strategy to support TGR BioSciences Pty Ltd's immunoassay technology in its merger with Sygnis AG.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.